Gynius Plus AB’s Post

More and more funding entities (Germany - "Anchoring sustainability considerations in DFG funding activities ": https://lnkd.in/e85iRM8k) require action from research labs to reduce their environmental footprint - and prove it. That's a very positive and important sign. #Grenova can provide you with a personalized impact analysis regarding pipette tips and microplates usage - and offers solutions to minimize carbon emissions, reduce plastic waste and save water. #reduce #reuse #recycle #sustainability

How many other funding bodies will take this approach to making a real difference to being #sustainable What are most labs doing to make a difference. Sustainability comes in many different forms: - reduction in plastic - reduction in animal products - moving to xeno-free - recycling programmes - low energy equipment - ordering from UK companies to reduce carbon footprint for long distance shipping - bulk ordering to reduce deliveries 🚚 I am a Green Lab ambassador - are you? #sustainability #greener #reduce #reuse #recycle

Biomedical research is harmful to our health. I’m not crazy. I know its importance to improve health. But, like all other human activities, what scientists do in the lab has consequences for the environment. Luckily, an increasing number of leading organizations show commitment to greener research. For example, Cancer Research UK (CRUK) included sustainability as a key pillar of its strategy. To display its engagement, the organization included sustainability in its positioning statement. This means that Cancer Research UK must be sustainable to accomplish its mission and defeat cancer. What are the implications for researchers? Cancer Research UK just released new requirements. Starting from 2026: 💲 Researchers applying for most funding schemes must hold My Green Lab or LEAF accreditations, proving their work's sustainability. ♻ Data sharing will be encouraged to avoid replicating unnecessary experiments Are scientists left alone in their journey? Of course not. Cancer Research UK will support them through various communication channels and other initiatives to make the cancer research field greener.

We are excited to announce our first ever #EAAMOSocialHackathon as part of the ACM Conference on Equity and Access in Algorithms, Mechanisms, and Optimization (EAAMO) 🌟   This event is organized in collaboration with the Universidad Autónoma de San Luis Potosí and IPICyT.   💡 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐒𝐨𝐜𝐢𝐚𝐥 𝐇𝐚𝐜𝐤𝐚𝐭𝐡𝐨𝐧? This event is a unique opportunity to address critical social issues through innovative technological solutions. Local partners will provide curated datasets and extensive context to inform participants’ solutions, ensuring they incorporate insights from impacted communities and policymakers. 📅 𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐃𝐚𝐭𝐞𝐬: • August: Kickoff at Virtual Colloquium (August 22, 2024) & dataset release • September: Project development & submissions • October: Finalists & pitches at ACM EAAMO '24 • November onwards: Collaboration with policymakers ➡ 𝐖𝐡𝐲 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞? • By submitting a proposal, you and your team members get free virtual registration to attend EAAMO’24 • Finalists get one travel grant per team to attend EAAMO’24 in person • The winning team gets a monetary prize as well as the opportunity to collaborate directly with local policymakers to implement their solution 💡 𝐓𝐡𝐢𝐬 𝐘𝐞𝐚𝐫’𝐬 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞: 𝐓𝐚𝐜𝐤𝐥𝐢𝐧𝐠 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐢𝐧 𝐌𝐞𝐱𝐢𝐜𝐨 This event will focus on addressing breast cancer disparities in Mexico through innovative technological solutions. Join us to make a real impact by leveraging the power of algorithms, optimization, and mechanism design. 𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐦𝐚𝐤𝐞 𝐚 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞? 𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐠𝐞𝐭 𝐬𝐭𝐚𝐫𝐭𝐞𝐝! 🔗 https://lnkd.in/gy8bAWYu 

Academic research doesn’t happen in a vacuum! Pan-regional, multidisciplinary collaborations hold huge potential for tackling health challenges. As part of The Connectivity Mix insight paper and event series, we will be discussing how to use a network approach to turn research at the interface between medicine and technology into reality.  To ensure successful translation into real-world impact, engagement with key stakeholders is essential. As Colin Watts commented at Connect: Health Tech – Live! last year: “If you’re developing technologies, you need an end-to-end pipeline with early engagement of end-users to ensure that they are actually used.” Colin is Chair of the Brain Cancer Programme at the University of Birmingham and a Clinical Lead in the EPSRC Interdisciplinary Research Collaboration (IRC) in Targeted Delivery for Hard-to-Treat Cancers. This national collaboration takes researchers from different disciplines and seeks to increase the efficacy of existing drugs and open the door for new therapeutic agents. The Interdisciplinary Research Collaboration includes regions from around the country and actively involves clinicians in the research process. A collaborative research ecosystem has been developed across multiple disciplines with active engagement with the full path to successful adoption, from manufacturing challenges to end-user engagement.  Join the waiting list for our Cambridge event to be the first to hear about new tickets and receive the paper when it launches: https://lnkd.in/ekAWei9y #ConnectivityMix #JoiningTheDots #SciencePark #Collaboration #Innovation

Why does scientific research not evolve as a solution to problems in Brazil? That's the question we try to answer and understand by talking to Doctor BEATRIZ DA COSTA AGUIAR ALVES REIS, a biologist, researcher at the Faculdade de Medicina do ABC and lead researcher and co-founder at LiqSci: a Sthorm startup, pioneering in research and development of liquid biopsy methods that can detect cancer and other diseases at early stages easily, quickly, and painlessly. Its products emerged from decades of research and are now moving quickly towards clinical application, aiming to reach those who need it most: tens of thousands of patients who suffer from late discovery of a serious disease and therefore fail to seek adequate treatment in time. #FromPaperToThePeople is a series of content about the importance of infrastructure for scaling up research so that it moves from paper to those who need it. #Sthorm #FindTheOthers #BreastCancer #Liqsci #People

🎉 Exciting News from Traverse Consulting 🎉 We eagerly announce that our co-founder, Jean-Loup Romet-Lemonne, has authored a creative essay expanding his influential footprint beyond the realms of immunology and cancer therapy to social science. With decades of experience guiding both public and private organizations towards innovation and success, Jean-Loup's insights are central to our achievements in the field of biotech . 📚 Book Highlight: "The Bio-Intelligence: The social well-being in the light of our biological body" In today’s society, achieving social well-being is more critical than ever. In this essay, Jean-Loup, and co-author François-Marie Pons, explore the fascinating parallels between our biological equilibrium and societal harmony. This essay delves into how the very cells of our organism could hold the keys to living a more integrated life within our communities. Through their unique perspectives— which blend medical expertise and a passion for human relations—Jean-Loup and François-Marie challenge us to rethink our approach to social wellness. Their message is clear: the solutions to our collective malaise lie within us, waiting to be unlocked through a deeper understanding of our biological makeup.   To discover more about his book, visit: https://lnkd.in/gqbKqeXH Here's to innovating for a healthier society, inside and out! #TraverseConsulting #BioIntelligence #SocialWellBeing #Innovation #BookRelease

This is an insightful and timely article. According to a recent analysis published by Cruchbase, based on data through May 2024, the amount of capital raised through Series A funding for biotechs is expected to rise above last year's total, but fewer companies are actually receiving the investments. The projected # of biotechs receiving Series A for FY2024 is projected to be ~20% lower than 2023 and ~40% lower than 2019 / 2020. With fewer companies receiving larger amounts of capital, there is a significant funding gap and a tremendous opportunity for organizations, like Blackbird Laboratories and the others mentioned in this article, to identify promising research, leverage their technical expertise to de-risk early development pitfalls and to accelerate the development of novel and valuable medicines. #Innovation #Entrepreneurship #Biotech

Associate Professor Agnes Yong is one of the 2024 Research Innovation and Impact Grant recipients. Associate Professor Yong’s project, “Personalised place-of-care manufactured immune cells for blood cancer” aims to manufacture personalised BCMA-CAR T-cells for patients who have exhausted all other treatment options. Manufacturing CAR T-cells in-house will not only significantly reduce the cost of treatment, but also cut down wait times from four weeks to 12 days. Click here to read more about Associate Professor Yong’s project: https://lnkd.in/gp2Bm6he The 2024 Research Innovation and Impact Grant Program, co-funded by the WA Future Health Research and Innovation Fund, aims to fund new research projects that will improve Western Australian healthcare. #RPHRF #RPHResearchFoundation

🌎 We Collaborate to Build Global Solutions for #WomensHealth. 🤝 Leading Dutch and U.S. companies are joining forces to develop groundbreaking #diagnostic tools and treatments in gynecological #health. 👩🔬 The Dutch companies, CC Diagnostics, Predica Diagnostics BV, ViciniVax B.V. and SHE Health Clinics have formed an alliance to develop tools and procedures for early detection and proper treatment of cervical cancer. The American company, Nine Diagnostics is developing a novel proteomics and metabolomics platform for measuring treatment effectiveness and cancer disease burden such as in ovarian cancer. 🚀 The collaboration is supported by The Netherlands Innovation Network in Boston (NIN). NIN is the #science and #technology arm of the Dutch diplomatic network in the United States. The NIN aims to foster bilateral science and innovation cooperation between the Dutch and American government, knowledge institutes, industry, and SMEs around key enabling technologies. 💎 The activities of the Netherlands Innovation Network help execute the international knowledge and innovation agenda of the Dutch Ministerie van Economische Zaken. #collaboration #womenshealth #cervicalcancer #ovariancancer #diagnostics Founded VentureLab North Tech4Eva - The global Femtech accelerator EIT Health Draper University Kim Tran Kaoutar Ashour Subah Zaeem